FindTrial
Sign In

Median Effective Dose of intranasal dexmedetomidine sedation for Pediatric transthoracic echocardiography between the children with and without history of cardiac operation: A Biased-Coin Up-and-Down Sequential Allocation Trial

Median Effective Dose of intranasal dexmedetomidine sedation for Pediatric transthoracic echocardiography between the children with and without history of cardiac operation: A Biased-Coin Up-and-Down Sequential Allocation Trial

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-16009846
Enrollment
Unknown
Registered
2016-11-13
Start date
2016-11-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative children with congenital heart disease

Interventions

underwent cardiac surgery children:intranasal dexmedetomidine sedation
normal:intranasal dexmedetomidine sedation

Sponsors

Children's Hospital Affiliated to Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All children who presented for an echocardiography from October to November 2016, patients enrolled into this study aged 4 and 36 months old and to be classified as American Society of Anesthesiologists physical status I or II

Exclusion criteria

Exclusion criteria: 1. known allergy to dexmedetomidine; 2. recent treatment with a-2 adrenergic receptor agonist; 3. renal or hepatic dysfunction; 4. nasal discharges; 5. history of preterm birth.

Design outcomes

Primary

MeasureTime frame
dose of dexmedetomidine required;—

Secondary

MeasureTime frame
Sedation Induction Time;Wake-up Time;—

Countries

China

Contacts

Public ContactShengfen Tu

Chongqing Medical University affiliated Children's Hospital

519194496@qq.com+86 13983416114

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026